David Jean

  Paracetamol IV (intravenous paracetamol) is a widely used analgesic and antipyretic medication administered directly into the bloodstream, offering rapid relief from pain and fever. It is especially beneficial in clinical settings where oral administration is not feasible, such as during surgery, post-operative care, or in critically ill patients. The intravenous form ensures faster onset of action and better bioavailability compared to oral or rectal routes. As the demand for effective non-opioid pain management increases globally, IV paracetamol has gained popularity among healthcare professionals. Its role in multimodal analgesia strategies, often used to minimize opioid consumption, has further driven its adoption. With increasing surgical procedures and hospital admissions, the market for paracetamol IV continues to grow steadily across developed and emerging regions. According to SPER market research,  ‘ Paracetamol IV Market  Growth, Size, Trends Analysis - By In...